DE69221708D1 - Neue Translationsaktivierungssequenz - Google Patents

Neue Translationsaktivierungssequenz

Info

Publication number
DE69221708D1
DE69221708D1 DE69221708T DE69221708T DE69221708D1 DE 69221708 D1 DE69221708 D1 DE 69221708D1 DE 69221708 T DE69221708 T DE 69221708T DE 69221708 T DE69221708 T DE 69221708T DE 69221708 D1 DE69221708 D1 DE 69221708D1
Authority
DE
Germany
Prior art keywords
activation sequence
new translation
translation activation
sequence
translational activating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69221708T
Other languages
English (en)
Other versions
DE69221708T2 (de
Inventor
Charles Lee Hershberger
Jane Larowe Sterner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE69221708D1 publication Critical patent/DE69221708D1/de
Application granted granted Critical
Publication of DE69221708T2 publication Critical patent/DE69221708T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Programmable Controllers (AREA)
DE69221708T 1991-12-18 1992-12-15 Neue Translationsaktivierungssequenz Expired - Fee Related DE69221708T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81104591A 1991-12-18 1991-12-18

Publications (2)

Publication Number Publication Date
DE69221708D1 true DE69221708D1 (de) 1997-09-25
DE69221708T2 DE69221708T2 (de) 1998-01-22

Family

ID=25205390

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69221708T Expired - Fee Related DE69221708T2 (de) 1991-12-18 1992-12-15 Neue Translationsaktivierungssequenz

Country Status (12)

Country Link
EP (1) EP0547873B1 (de)
JP (1) JPH05276950A (de)
AT (1) ATE157122T1 (de)
AU (1) AU663139B2 (de)
CA (1) CA2085447A1 (de)
DE (1) DE69221708T2 (de)
DK (1) DK0547873T3 (de)
ES (1) ES2104856T3 (de)
GR (1) GR3024762T3 (de)
HU (1) HU218269B (de)
IL (1) IL104086A (de)
MX (1) MX9207265A (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002051238A2 (en) 2000-12-26 2002-07-04 Monsanto Technology Llc Recombinant dna vectors for expression of somatotropins

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5126249A (en) * 1989-05-09 1992-06-30 Eli Lilly And Company Enzymatic removal of a protein amino-terminal sequence
IL99100A0 (en) * 1990-08-13 1992-07-15 Lilly Co Eli Improved bacteriophage lambda pl promoters

Also Published As

Publication number Publication date
MX9207265A (es) 1993-07-01
EP0547873A2 (de) 1993-06-23
ES2104856T3 (es) 1997-10-16
DK0547873T3 (da) 1997-09-15
AU663139B2 (en) 1995-09-28
EP0547873B1 (de) 1997-08-20
HU218269B (hu) 2000-06-28
GR3024762T3 (en) 1997-12-31
AU3019592A (en) 1993-06-24
EP0547873A3 (de) 1994-08-31
JPH05276950A (ja) 1993-10-26
ATE157122T1 (de) 1997-09-15
IL104086A0 (en) 1993-05-13
CA2085447A1 (en) 1993-06-19
HUT65816A (en) 1994-07-28
DE69221708T2 (de) 1998-01-22
HU9203981D0 (en) 1993-04-28
IL104086A (en) 1998-03-10

Similar Documents

Publication Publication Date Title
PT1359222E (pt) Factor viii hibrido humano/suino
DE69028346T2 (de) Härtbare Siliconmassen
DE69116495T2 (de) Rekombinante Transglutaminase
KR950700581A (ko) 서류 처리기(Document handler)
NO912883D0 (no) Fleksibelt oppvarmingselement.
FI953302A (fi) Uudet peptidit
NO971248D0 (no) 5<alfa>-reduktaseinhibitorer
DE69306754T2 (de) Flexible Zusatzablenkspule
DK245689A (da) Bacillus thuringiensis transformationer
DE69104637D1 (de) Umschaltdrucker.
ATE157122T1 (de) Neue translationsaktivierungssequenz
NO974726D0 (no) Glucose-induktibel, rekombinant, viral vektor
IT240544Y1 (it) Attuatore lineare con microinterruttori di fine corsa ad elevatasemplicita'di regolazione.
DE59001828D1 (de) Spulenreifvorrichtung.
DE69014171D1 (de) Schwundarm härtbare Zusammensetzung auf Basis von ungesättigten Polyesterbasen.
NO901434L (no) Neurotrofiske peptider.
FR2703124B1 (fr) Soufflet elastiquement deformable.
DE59811771D1 (de) Faltenbalg mit imprägnierung
FR2709944B1 (fr) Agrafe chirurgicale.
ITFI920071A1 (it) Antigeni ricombinanti proteici ad aumentata immunogenicita' contenenti il peptide rappresentato dalla sequenza vqgeesndk
DE59002615D1 (de) Elektrisches Eintreibgerät.
Bruce UNBOS instructional operating system source code
FR2710241B3 (fr) Composition énergétique à base d'acides aminés glycogéniques.
NO912738L (no) Fleksibel pose.
NO905166D0 (no) Mekanisk klemme.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee